- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04028557
An Implementation Model for Clinical Decision Support for Heart Failure Prescribing
May 4, 2022 updated by: University of Colorado, Denver
Development and Validation of an Integrated Implementation Model for Clinical Decision Support for Heart Failure Prescribing
The objective of this proposal is to compare clinical outcomes, implementation metrics (i.e., patient reach and clinician adoption), and clinician preferences of two designs (customized vs. commercial) of a clinical decision support (CDS).
Beta blocker prescribing for patients with heart failure will be used as a test case.
The best practices in CDS design, including the user-centered design will be incorporated into the customized CDS and compared to a commercially-available CDS in the electronic health record using a cluster randomized trial.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
118
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Study subjects are providers
Inclusion Criteria:
- Prescribing primary care clinicians at University of Colorado Health (UCHealth) who provide care for patients with heart failure and reduced ejection fraction
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Customized CDS
The customized CDS will be designed and implemented with comprehensive application of known best practice principles in CDS design.
The recommendation will be to initiate an evidence-based beta blocker for heart failure.
|
Active computerized clinical decision support alert within the electronic health record that recommends initiation of an evidence-based beta blocker for heart failure and reduced ejection fraction.
Other Names:
|
Active Comparator: Commercial CDS
The commercial CDS is available to all institutions using the Epic electronic health record vendor, but violates some CDS design best practices, notably not being tailored to the end users of a given health system.
The recommendation will be to initiate an evidence-based beta blocker for heart failure.
|
Active computerized clinical decision support alert within the electronic health record that recommends initiation of an evidence-based beta blocker for heart failure and reduced ejection fraction.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in prescription of Beta blocker (BB)
Time Frame: 6 months post CDS implementation
|
Number of prescriptions of an evidence based BB during a primary care office visit.
|
6 months post CDS implementation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Reach
Time Frame: 6 months post CDS implementation
|
The proportion of unique patients with heart failure who were seen by primary care and not taking an evidence based BB who the CDS fired for.
|
6 months post CDS implementation
|
Clinician Adoption
Time Frame: 6 months post CDS implementation
|
The proportion of CDS who were not outright dismissed by the clinician.
|
6 months post CDS implementation
|
Factors Influencing Clinician Adoption of the CDS per Qualitative Interviews
Time Frame: 6 months post CDS implementation
|
Clinician-reported factors that influence adoption of the CDS.
|
6 months post CDS implementation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Katy E Trinkley, PharmD, University of Colorado, Denver
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 24, 2019
Primary Completion (Actual)
September 23, 2019
Study Completion (Actual)
September 23, 2019
Study Registration Dates
First Submitted
July 8, 2019
First Submitted That Met QC Criteria
July 18, 2019
First Posted (Actual)
July 22, 2019
Study Record Updates
Last Update Posted (Actual)
May 6, 2022
Last Update Submitted That Met QC Criteria
May 4, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-0020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
US Department of Veterans AffairsCompleted
Clinical Trials on Decision Support Systems, Clinical
-
Kenya Medical Research InstituteUnknown
-
University Hospital, LilleRegional Agency of Sante Nord Pas-de-Calais; OméDIT (Observatory of Medicines...Not yet recruitingAcute Renal Failure | Patient Acceptance of Health Care
-
Peking University Third HospitalRecruiting
-
University of CalgaryAlberta Health services; University of Alberta; Covenant HealthCompletedStrategy for Uptake of Processes for Recognizing and Responding to Acute Kidney Injury (SUPPORT AKI)Acute Kidney InjuryCanada
-
University Hospital, LinkoepingRecruitingHypercholesterolemia, Familial | Clinical Decision SupportSweden
-
HealthPartners InstituteUniversity of Pittsburgh; National Institute of Dental and Craniofacial Research... and other collaboratorsCompleted
-
University of CalgaryAlberta Innovates Health SolutionsUnknownBrain Injuries | Pulmonary EmbolismCanada
-
Indiana UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingFunctional Gastrointestinal DisordersUnited States
-
Vanderbilt University Medical CenterNational Institute of Allergy and Infectious Diseases (NIAID); University of...CompletedPneumonia ChildhoodUnited States
-
University of Massachusetts, WorcesterAgency for Healthcare Research and Quality (AHRQ); Baycrest Centre for Geriatric...CompletedPatient Safety | Prescribing Practices | Laboratory Monitoring PracticesUnited States